Nextage Therapeutics Ltd

Tel Aviv Stock Exchange NXTG.TA

Nextage Therapeutics Ltd Free Cash Flow Per Share for the year ending December 31, 2023: USD -0.02

Nextage Therapeutics Ltd Free Cash Flow Per Share is USD -0.02 for the year ending December 31, 2023. Free cash flow per share is the free cash flow generated per share. Indicates investment potential based on cash flow generation.
  • Nextage Therapeutics Ltd Free Cash Flow Per Share for the year ending December 31, 2021 was USD -0.03, a 84.79% change year over year.
  • Nextage Therapeutics Ltd Free Cash Flow Per Share for the year ending December 31, 2020 was USD -0.20.
Key data
Date Free Cash Flow Per Share Return on Assets (ROA) Return on Equity (ROE) Return on Capital Employed (ROCE)
Market news
SV Wall Street
Tel Aviv Stock Exchange: NXTG.TA

Nextage Therapeutics Ltd

CEO Mr. Abraham Dreazen
IPO Date Aug. 12, 2002
Location Israel
Headquarters Einstein St. Building 13B
Employees 42
Sector Consumers Staples
Industries
Tobacco Alcoholic Beverages Bread & Bakery Cosmetics Glass Personal Care Pharmaceuticals Snack Foods
Description

Nextage Therapeutics Ltd develops cannabinoid-based products. The company is based in Ness Ziona, Israel.

StockViz Staff

February 6, 2025

Any question? Send us an email